Case analysis reports successful outcomes in treating infective endocarditis with oritavancin, suggesting a viable alternative to traditional antibiotic regimens.
Oritavancin is emerging as a potential alternative to standard antibiotic regimens in the treatment of infective endocarditis caused by gram-positive bacteria, though evidence remains limited. We hereby report 7 cases of enterococcal endocarditis treated with oritavancin as consolidation therapy, resulting in 6 cures and 1 relapse.
No takes yet. Share an insight, caveat, or question.
Frondizi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: